API
< Back to situation

[REVISION HISTORY]

National hepatitis screening expansions

3 recorded revisions of this situation.

What changed

2026-07-29 01:31 UTC → 2026-08-11 01:42 UTC · added removed

Since July 2026 2026, Italy and India have intensified national hepatitis screening and treatment to meet the WHO 2030 elimination goal. In Italy, World Hepatitis Day (28 July) spurred calls widespread local and systematic screening efforts. In Piemonte, rapid HCV tests were offered at workplaces, while Ferrara organized public information sessions. In Amelia, a screening initiative led by the Santa Maria di Terni Hospital revealed a 5% positivity rate for hepatitis B, hepatitis C, and HIV among participants. Experts, including Professor Miriam Lichtner, have called for systematic hospital‑based hospital-based testing of for hepatitis B, C C, and the Delta variant on during patient admission, targeting people admissions, particularly for those born before 1991 who missed vaccination. Experts also expanded 1991. Additionally, the “Test in the City” programme, providing rapid on‑site programme continues to provide rapid, on-site screening for vulnerable groups, including migrants and people who use drugs, migrants and other vulnerable groups at workplaces, religious venues venues, workplaces, and adult‑language adult-language schools. These moves build on earlier free screening events in regions such as Piemonte, Ferrara and Amelia. India’s National Viral Hepatitis Control Programme (NVHCP) has been scaled up to offer free screening, diagnostics diagnostics, and treatment for hepatitis B and C through district health centres, centres and Ayushman Arogya Mandirs and Mandirs. The programme utilizes a paper‑less paper-less MIS portal that monitors patients for digital monitoring and links to a toll‑free helpline (1800‑11‑6666). The programme now supports universal birth‑dose birth-dose hepatitis B vaccination within 24 hours of delivery under the Universal Immunisation Programme. Surveillance data cited from 2021 show hepatitis B prevalence of 0.85 % and hepatitis C prevalence of 0.29 % among those tested. delivery. Officials reaffirm the 2030 elimination target, noting note that India accounts for roughly 12 % 12% of the global hepatitis burden. A WHO 2026 report highlighted a 17 % 17% rise in hepatitis B mortality worldwide and warned that the EU/EEA is likely to miss the 2030 target, underscoring the broader global testing and treatment gap that both countries are trying to close. gap.

Versions

  1. 2026-08-11 01:42 UTC National hepatitis screening expansions
  2. 2026-07-29 01:31 UTC National hepatitis screening expansions
  3. 2026-07-28 18:36 UTC National hepatitis screening expansions
  4. 2026-07-27 08:09 UTC National hepatitis screening expansions

Select a version to see what changed compared to the one before it.